Gates et al., 2008 - Google Patents
Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosisGates et al., 2008
- Document ID
- 9259906507714121900
- Author
- Gates A
- Frasca S
- Nyaoke A
- Gorton T
- Silbart L
- Geary S
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
In a previous study, signature sequence mutagenesis (SSM) was used to identify a mutant with a disruption of the gene encoding the metabolic factor, dihydrolipamide dehydrogenase, and that mutant was designated Mg 7. The current study assessed the …
- 229960005486 vaccines 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nicholas et al. | An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings | |
Gates et al. | Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis | |
Sadeyen et al. | Analysis of immune responses induced by avian pathogenic Escherichia coli infection in turkeys and their association with resistance to homologous re-challenge | |
US20120045475A1 (en) | Live attenuated vaccines | |
Salehi et al. | Assessment of immunity against avian colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers | |
US8404253B2 (en) | Modified live (JMSO strain) Haemophilus parasuis vaccine | |
Kanci et al. | Evaluation of Mycoplasma gallisepticum (MG) ts-304 vaccine as a live attenuated vaccine in turkeys | |
JP5745731B2 (en) | Salmonella vaccine | |
El-Naggar et al. | A novel locally prepared inactivated bivalent mycoplasma vaccine for chicken flocks in Egypt | |
Papazisi et al. | A modified live Mycoplasma gallisepticum vaccine to protect chickens from respiratory disease | |
JP2718518B2 (en) | Mycoplasma vaccine | |
Ferguson-Noel et al. | Evaluation of Mycoplasma gallisepticum K-strain as a live vaccine in chickens | |
US20160158336A1 (en) | Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use | |
Hamdy et al. | Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3 | |
WO1993016728A1 (en) | Improved vaccin against brucella abortus | |
Nandre et al. | Comparison of a live attenuated Salmonella Enteritidis vaccine candidate secreting Escherichia coli heat-labile enterotoxin B subunit with a commercial vaccine for efficacy of protection against internal egg contamination by Salmonella in hens | |
Chengappa et al. | A streptomycin-dependent live Pasteurella multocida type-3 vaccine for the prevention of fowl cholera in turkeys | |
Amen et al. | Evaluating the efficacy of commercial Escherichia coli killed vaccine in broiler chickens | |
US10188715B2 (en) | Swine dysentery vaccine | |
Raghavan et al. | Effect of vaccination against pneumonia on the survival of bighorn sheep (Ovis canadensis) commingled with carrier animals | |
Tseng et al. | Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate | |
WO2016001176A1 (en) | Novel veterinary vaccine compositions for use in the treatment of infectious diseases caused by or associated with pasteurellaceae family bacteria | |
Subramaniam et al. | Bighorn sheep× domestic sheep hybrids survive Mannheimia haemolytica challenge in the absence of vaccination | |
US5718903A (en) | Vaccine comprising Brucella abortus which has O polysaccharide antigen absent | |
Harkinezhad et al. | Protection of budgerigars (Melopsittacus undulatus) against Chlamydophila psittaci challenge by DNA vaccination |